Related Experiment Video
Updated: Jul 5, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Recent progress in antiretrovirals--lessons from resistance.
Catherine S Adamson1, Eric O Freed
1Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702-1201, USA.
Drug Discovery Today
|May 13, 2008
Summary
New antiretroviral drugs targeting diverse HIV-1 replication stages are crucial. This review highlights novel inhibitors for viral entry, integration, and maturation to combat drug resistance.
Area of Science:
- Virology
- Infectious Diseases
- Drug Discovery
Background:
- HIV-1 vaccine development has faced setbacks, increasing reliance on antiretroviral therapy (ART).
- Current ART, including reverse transcriptase and protease inhibitors, has improved patient survival.
- Viral resistance necessitates the development of novel antiretrovirals targeting different replication steps.
Purpose of the Study:
- To review recent advancements in antiretroviral drug discovery.
- To focus on novel inhibitors targeting viral entry, DNA integration, and particle maturation.
- To address the urgent need for new therapeutic strategies against HIV-1.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of drug discovery efforts targeting specific HIV-1 replication phases.
- Synthesis of information on novel inhibitor classes and mechanisms of action.
Main Results:
- Identification of promising novel inhibitors for viral entry.
- Progress in developing agents targeting HIV-1 DNA integration into the host genome.
- Advancements in discovering compounds that inhibit virus particle maturation.
Conclusions:
- Novel antiretroviral agents targeting diverse replication steps are essential for overcoming resistance.
- Continued research into inhibitors of viral entry, integration, and maturation holds significant therapeutic potential.
- These new drug classes offer hope for improved long-term management of HIV-1 infection.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...